Skip to main content
placeholder image

SP-103 Scandium-47 and lutetium-177 radiolabelling and stability studies of 1st and 2nd generation DOTA-triphenylphosphonium ligands ¿ potential radionuclide theranostics for treatment of glioblastoma multi-forme

Journal Article


Abstract


Publication Date


  • 2021

Citation


  • Wyatt, N., Hogan, L., Pellegrini, P., Roberts, M., Hall, A., Smith, N., . . . Fraser, B. (2021). SP-103 Scandium-47 and lutetium-177 radiolabelling and stability studies of 1st and 2nd generation DOTA-triphenylphosphonium ligands ¿ potential radionuclide theranostics for treatment of glioblastoma multi-forme. Nuclear Medicine and Biology, 96, s93-s94. doi:10.1016/s0969-8051(21)00420-0

Web Of Science Accession Number


Start Page


  • s93

End Page


  • s94

Volume


  • 96

Abstract


Publication Date


  • 2021

Citation


  • Wyatt, N., Hogan, L., Pellegrini, P., Roberts, M., Hall, A., Smith, N., . . . Fraser, B. (2021). SP-103 Scandium-47 and lutetium-177 radiolabelling and stability studies of 1st and 2nd generation DOTA-triphenylphosphonium ligands ¿ potential radionuclide theranostics for treatment of glioblastoma multi-forme. Nuclear Medicine and Biology, 96, s93-s94. doi:10.1016/s0969-8051(21)00420-0

Web Of Science Accession Number


Start Page


  • s93

End Page


  • s94

Volume


  • 96